awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36176934-09AC6125-611D-464D-BC6B-2289AF111AA3
Q36176934-09AC6125-611D-464D-BC6B-2289AF111AA3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36176934-09AC6125-611D-464D-BC6B-2289AF111AA3
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.
P2860
Q36176934-09AC6125-611D-464D-BC6B-2289AF111AA3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36176934-09AC6125-611D-464D-BC6B-2289AF111AA3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a38cd889440091cea069559a02d8eba77a7812ee
P2860
Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study